GHRP-6 Research Evidence
The GHRP-6 evidence base: trials, journals, and what the data does not yet show.
Key Findings at a Glance
• GHRP-6 causes near-universal appetite stimulation through potent ghrelin receptor activation in the hypothalamus, an effect strong enough to confound metabolic research designs. • GHRP-6 was the first synthetic growth hormone secretagogue discovered, paving the way for the entire GHRP family including GHRP-2, Hexarelin, and Ipamorelin. • GHRP-6 raises cortisol and prolactin levels in addition to growth hormone, distinguishing it from more selective secretagogues and limiting its utility in isolated GH research. • Research shows GHRP-6 has cytoprotective effects on gastric mucosa independent of its GH-releasing activity, sharing unexpected overlap with gut-protective peptides like BPC-157.
Cardioprotective Research
Emerging research suggests GHRP-6 may possess cardioprotective properties through mechanisms potentially independent of growth hormone release, including direct effects on cardiac myocytes and vascular endothelial cells. Studies in ischemia-reperfusion injury models demonstrate reduced infarct size, improved left ventricular function, and decreased cardiomyocyte apoptosis following GHRP-6 treatment, with some studies showing up to 40% reduction in infarct area. Research indicates the peptide may activate cardioprotective signaling cascades including the PI3K/Akt pathway and reduce oxidative stress markers in cardiac tissue. GHRP-6 has been studied for effects on cardiac fibrosis, with some research suggesting reduced collagen deposition and improved ventricular compliance in heart failure models. These cardiovascular research applications have generated interest in GHRP-6 for coronary artery disease studies, post-myocardial infarction recovery research, and investigations into peptide-based cardioprotection strategies.
Trials and reviews
- Frieboes sleep + endocrine studyNeuroendocrinology1995
increased stage-2 NREM sleep alongside cortisol/ACTH rises · small human study
References
- GHRP-6 and the discovery of the ghrelin receptor · Bowers CY · 2012
- Bowers CY, et al. On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology. 1984;114(5):1537-1545. · Bowers CY, Momany FA, Reynolds GA, Hong A · 1984
- Acute dexamethasone administration enhances GH responsiveness to GH releasing peptide-6 (GHRP-6) in man. · Pinto AC, Finamor FE Jr, Lengyel AM · 1999
- Howard AD, et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science. 1996;273(5277):974-977. · Howard AD, Feighner SD, Cully DF, Arena JP, Liberator PA, Rosenblum CI, Hamelin M, Hreniuk DL, Palyha OC, Anderson J, Paress PS, Diaz C, Chou M, Liu KK, McKee KK, Pong SS, Chaung LY, Elbrecht A, Dashkevicz M, Heavens R, Rigby M, Sirinathsinghji DJ, Dean DC, Melillo DG, Patchett AA, Nargund R, Griffin PR, DeMartino JA, Gupta SK, Schaeffer JM, Smith RG, Van der Ploeg LH · 1996
- Growth hormone response to GHRH, GHRP-6 and GHRH + GHRP-6 in patients with polycystic ovary syndrome. · Micić D, Kendereski A, Popović V et al. · 1996
- Synthetic Growth Hormone-Releasing Peptides (GHRPs) - NIH · Berlanga-Acosta J, Abreu-Cruz A, Herrera DGB, Mendoza-Marí Y, Rodríguez-Ulloa A, García-Ojalvo A, Falcón-Cama V, Hernández-Bernal F, Beichen Q, Guillén-Nieto G · 2017
- Kojima M, Kangawa K. Ghrelin: structure and function. Physiological Reviews. 2005;85(2):495-522. · Kojima M, Kangawa K · 2005
- Growth hormone secretion elicited by GHRH, GHRP-6 or GHRH plus GHRP-6 in patients with microprolactinoma and macroprolactinoma before and after bromocriptine therapy. · Popovic V, Simic M, Ilic L et al. · 1998
- Pharmacokinetic study of Growth Hormone-Releasing Peptide 6 ...
- Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: evidence that GHRP-6 main action is exerted at the hypothalamic level. · Popovic V, Damjanovic S, Micic D et al. · 1995
- Growth hormone releasing peptide-6 (GHRP-6) prevents ... · Berlanga-Acosta J, Cibrian D, Valiente-Mustelier J, Suárez-Alba J, García-Ojalvo A, Falcón-Cama V, Jiang B, Wang L, Guillén-Nieto G · 2024
- Leal-Cerro A, et al. Growth hormone (GH)-releasing peptide-6 requires endogenous hypothalamic GH-releasing hormone for maximal GH stimulation. J Clin Endocrinol Metab. 1998;83(4):1186-1189. · Pandya N, DeMott-Friberg R, Bowers CY, Barkan AL, Jaffe CA · 1998